Mesothelioma is an aggressive cancer that is associated with exposure to asbestos.
Although asbestos is banned in several countries, including the UK, an epidemic of …

Malignant mesothelioma is a universally lethal cancer that is increasing in incidence
worldwide. There is a dearth of effective therapies, with only one treatment (pemetrexed and …

Malignant mesothelioma (MM) is a rare, highly aggressive tumor that arises from the surface
serosal cells (pleural, peritoneal and pericardial cavities). Epidemiological and clinical data …

Malignant pleural mesothelioma (MPM) is a rare and fatal disease of the pleural lining. Up to
80% of the MPM cases are linked to asbestos exposure. Even though its use has been …

Malignant mesothelioma is an aggressive cancer whose pathogenesis is causally linked to
occupational exposure to asbestos. Familial clusters of mesotheliomas have been observed …

Malignant pleural mesothelioma (MPM) is a rare, yet lethal asbestos-induced cancer and
despite marked efforts to reduce occupational exposure, the incidence has not yet …

Mesothelioma is a rare tumor, frequently associated with asbestos exposure, arising from
pleura and peritoneum. Traditionally, diagnosis and treatment have been difficult in a clinical …

Malignant mesothelioma (MM) is an aggressive cancer of the mesothelium caused by
asbestos. Asbestos use has been reduced but not completely stopped. In addition, natural or …

Introduction: Mesothelioma is a rare type of cancer that is strongly tied to asbestos exposure.
Despite application of different modalities such as chemotherapy, radiotherapy and surgery …

Malignant mesothelioma (MM) is an aggressive tumour, which is strongly associated with
previous asbestos exposure and is resistant to all conventional anticancer therapies. An …